Lynavoy (linerixibat) for PBC Cholestatic Pruritus – FDA 2026 Overview
Lynavoy (linerixibat) is an oral ileal bile acid transporter (IBAT) inhibitor developed by GSK (GlaxoSmithKline) for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. It is supplied as 40 mg film‑coated tablets for twice‑daily…